1 Min Read
May 4 (Reuters) - Alk-abello A/S :
* Co’s house dust mite sublingual allergy immunotherapy tablet, Acarizax has been approved in Canada Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.